Content tagged with AD

• Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort
• Cortical thickness modeling and variability in Alzheimer’s disease and frontotemporal dementia
• OHBM 2023 ANNUAL MEETING
• AAIC 2023
• The APOE4 effect: structural brain differences in Alzheimer’s disease according to the age at symptom onset
• Classifying Alzheimer’s disease and frontotemporal dementia using machine learning with cross‐sectional and longitudinal magnetic resonance imaging data
• Sex differences in early-onset Alzheimer’s disease
• Classification between early onset Alzheimer´s disease and frontotemporal dementia using a single neuroimaging feature
• Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer’s Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines
• Emerging Topics in Artificial Intelligence (ETAI) 2022
• Evaluating the performance of Bayesian and frequentist approaches for longitudinal modeling: application to Alzheimer’s disease
• OHBM 2022 ANNUAL MEETING
• OHBM 2022 ANNUAL MEETING
• Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer’s disease
• AD/PD 2022 International Conference on Alzheimer’s and Parkinson’s Diseases
• AD/PD 2022 International Conference on Alzheimer’s and Parkinson’s Diseases
• Jornada STEM: visibilitzem l’enginyeria
• Statistical modelling of compromised longitudinal neuroimaging datasets: an application to alzheimer’s disease
• Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
• Emerging Topics in Artificial Intelligence (ETAI) 2021
• OHBM 2021 ANNUAL MEETING
• 2021 Annual Meeting of the ISMRM Iberian Chapter
• LXXII Reunión Anual de la Sociedad Española de Neurología
• AAIC NEURO-SCIENCE NEXT 2020
• XXIV Reunió Anual de la Societat Catalana de Neurologia
• Alzheimer’s Association International Conference (AAIC) 2020
• Alzheimer’s Association International Conference (AAIC) 2020
• Contribution of CSF biomarkers to early-onset Alzheimer’s disease and frontotemporal dementia neuroimaging signatures